From the melanoma cell lines A375 and SkMel28, both mutated on BRAF, resistant cell lines called A375RES and SkMel28RES were derived by selective growth in a medium containing increasing concentrations of the BRAF inhibitor, vemurafenib. This evidence concerns the gene BRAF and melanoma.